Introduction. To evaluate the decline of antibodies induced by SARS-CoV-2 infection, the individuals resident in 5 municipalities of the Autonomous Province of Trento, Northern Italy, who resulted IgG positive for anti-SARS-CoV-2 nucleocapsid (NC) in May 2020, were tested four months later. Methods. Anti-SARS-CoV-2 NC antibodies were detected using the Abbott SARS-CoV-2 IgG assay. Samples that gave a negative result were re-tested using the Liaison SARS-CoV-2 IgG assay to assess anti-spike (S) S1/S2 antibodies. The fifty-percent tissue culture infective dose (TCID50) neutralizing assay was performed on a subgroup of formerly positive sera. Statistical analysis was performed by STATA version 16.1 (STATA Corp., College Station, Texas, USA). Results. Overall, 480 out of 1159 participants became seronegative for anti-NC IgG antibodies. Age above 70 years and cough were associated with persistent anti-NC IgG levels. Most anti-NC IgG negative sera were positive for anti-S IgG (77.9%). The neutralization assay showed high concordance with anti-S antibodies positivity. Conclusion. In conclusion, a decline of anti-NC IgG values was recorded four months after the first evaluation. A high proportion of anti-NC seronegative individuals were positive for anti-spike IgG antibodies, which appear to persist longer and to better correlate with neutralization activity.

Anti-SARS-CoV-2 antibodies persistence after natural infection. a repeated serosurvey in Northern Italy / Fedele, G.; Stefanelli, P.; Bella, A.; Fiore, S.; Pancheri, S.; Benedetti, E.; Fabiani, C.; Leone, P.; Vacca, P.; Schiavoni, I.; Neri, A.; Carannante, A.; Simmaco, M.; Santino, I.; Zuccali, M. G.; Bizzarri, G.; Magnoni, R.; Benetollo, P. P.; Brusaferro, S.; Rezza, G.; Ferro, A.. - In: ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ. - ISSN 0021-2571. - 57:4(2021), pp. 265-271. [10.4415/ANN_21_04_01]

Anti-SARS-CoV-2 antibodies persistence after natural infection. a repeated serosurvey in Northern Italy

Simmaco M.;Santino I.;Brusaferro S.;
2021

Abstract

Introduction. To evaluate the decline of antibodies induced by SARS-CoV-2 infection, the individuals resident in 5 municipalities of the Autonomous Province of Trento, Northern Italy, who resulted IgG positive for anti-SARS-CoV-2 nucleocapsid (NC) in May 2020, were tested four months later. Methods. Anti-SARS-CoV-2 NC antibodies were detected using the Abbott SARS-CoV-2 IgG assay. Samples that gave a negative result were re-tested using the Liaison SARS-CoV-2 IgG assay to assess anti-spike (S) S1/S2 antibodies. The fifty-percent tissue culture infective dose (TCID50) neutralizing assay was performed on a subgroup of formerly positive sera. Statistical analysis was performed by STATA version 16.1 (STATA Corp., College Station, Texas, USA). Results. Overall, 480 out of 1159 participants became seronegative for anti-NC IgG antibodies. Age above 70 years and cough were associated with persistent anti-NC IgG levels. Most anti-NC IgG negative sera were positive for anti-S IgG (77.9%). The neutralization assay showed high concordance with anti-S antibodies positivity. Conclusion. In conclusion, a decline of anti-NC IgG values was recorded four months after the first evaluation. A high proportion of anti-NC seronegative individuals were positive for anti-spike IgG antibodies, which appear to persist longer and to better correlate with neutralization activity.
2021
covid-19; neutralizing antibodies; serology; aged; antibodies; viral; covid-19 serological testing; humans; sars-cov-2; antibodies, neutralizing; covid-19
01 Pubblicazione su rivista::01a Articolo in rivista
Anti-SARS-CoV-2 antibodies persistence after natural infection. a repeated serosurvey in Northern Italy / Fedele, G.; Stefanelli, P.; Bella, A.; Fiore, S.; Pancheri, S.; Benedetti, E.; Fabiani, C.; Leone, P.; Vacca, P.; Schiavoni, I.; Neri, A.; Carannante, A.; Simmaco, M.; Santino, I.; Zuccali, M. G.; Bizzarri, G.; Magnoni, R.; Benetollo, P. P.; Brusaferro, S.; Rezza, G.; Ferro, A.. - In: ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ. - ISSN 0021-2571. - 57:4(2021), pp. 265-271. [10.4415/ANN_21_04_01]
File allegati a questo prodotto
File Dimensione Formato  
Fedele_Anti-SARS-CoV-2-antibodies_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 257.81 kB
Formato Adobe PDF
257.81 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1608466
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact